"Why rare diseases affect us all," explains Prof Annette Grüters-Kieslich, chairwoman of the Eva Luise and Horst Köhler Foundation, in the Frankfurter Allgemeine Zeitung's publishing special "Rare Diseases."
It shows that research for rare diseases not only paves the way for new therapies, but can also serve as a guidepost for personalized precision medicine. Rare diseases also lead the way in terms of doctor-patient relationships, diagnostics and interdisciplinary collaboration.
One thing is clear: Rare does not equal insignificant!
Read the article here.
The entire issue can be found here.
